Abstract
Urocortin 3 (Ucn3) is recognized as a member of the corticotropin-releasing factor (CRF) family, which plays an important role in regulating food intake. We investigated the effects of centrally administered Ucn3 on food intake and gastric emptying in mice. Intracerebroventricular (ICV) administration of Ucn3 (0.1–1 nmol per mouse) decreased food intake in a dose-dependent manner. The inhibitory effect of Ucn3 on food intake was less potent than that of centrally administered CRF and Urocortin 1. ICV administration of Ucn3 (0.1–1 nmol per mouse) decreased the gastric emptying rate in a dose-dependent manner. Ucn3 decreased food intake in high-fat diet-fed obese mice as well as in lean mice. These results indicated that Ucn3 influences feeding behavior and gut motility, and may be a promising therapeutic target in the treatment of eating and functional gastrointestinal disorders.
Similar content being viewed by others
References
W. Vale, J. Spiess, C. Rivier, J. Rivier, Science 213, 1394–1397 (1981)
J. Vaughan, C. Donaldson, J. Bittencourt, M.H. Perrin, K. Lewis, S. Sutton, R. Chan, A.V. Turnbull, D. Lovejoy, C. Rivier, J. Rivier, P.E. Sawchenko, W. Vale, Nature 378, 287–292 (1995)
T.M. Reyes, K. Lewis, M.H. Perrin, K.S. Kunitake, J. Vaughan, C.A. Arias, J.B. Hogenesch, J. Gulyas, J. Rivier, W.W. Vale, P.E. Sawchenko, Proc. Natl. Acad. Sci. USA 98, 2843–2848 (2001)
K. Lewis, C. Li, M.H. Perrin, A. Blount, K. Kunitake, C. Donaldson, J. Vaughan, T.M. Reyes, J. Gulyas, W. Fischer, L. Bilezikjian, J. Rivier, P.E. Sawchenko, W.W. Vale, Proc. Natl. Acad. Sci. USA 98, 7570–7575 (2001)
R. Chen, K.A. Lewis, M.H. Perrin, W.W. Vale, Proc. Natl. Acad. Sci. USA 90, 8967–8971 (1993)
M. Hotta, T. Shibasaki, K. Arai, H. Demura, Brain Res. 823, 221–225 (1999)
A. Contarino, F. Dellu, G.F. Koob, G.W. Smith, K.F. Lee, W.W. Vale, L.H. Gold, Endocrinology 141, 2698–2702 (2000)
M. Spina, E. Merlo-Pich, R.K. Chan, A.M. Basso, J. Rivier, W. Vale, G.F. Koob, Science 273, 1561–1564 (1996)
J.L. Moreau, G. Kilpatrick, F. Jenck, Neuroreport 8, 1697–1701 (1997)
K. Inoue, G.R. Valdez, T.M. Reyes, L.E. Reinhardt, A. Tabarin, J. Rivier, W.W. Vale, P.E. Sawchenko, G.F. Koob, E.P. Zorrilla, J. Pharmacol. Exp. Ther. 305, 385–393 (2003)
T.L. Bale, M. Hoshijima, Y. Gu, N. Dalton, K.R. Anderson, K.F. Lee, J. Rivier, K.R. Chien, W.W. Vale, K.L. Peterson, Proc. Natl. Acad. Sci. USA 101, 3697–3702 (2004)
B.K. Brar, A.K. Jonassen, E.M. Egorina, A. Chen, A. Negro, M.H. Perrin, O.D. Mjos, D.S. Latchman, K.F. Lee, W. Vale, Endocrinology 145, 24–35 (2004)
C. Li, J. Vaughan, P.E. Sawchenko, W.W. Vale, J. Neurosci. 22, 991–1001 (2002)
C.P. Chu, D.L. Qiu, K. Kato, T. Kunitake, S. Watanabe, N.S. Yu, M. Nakazato, H. Kannan, Regul. Pept. 119, 53–59 (2004)
K. Kageyama, K. Hanada, T. Suda, Regul. Pept. 162, 18–25 (2010)
A. Fedeli, F. Policani, M. Ubaldi, A. Cippitelli, M. Massi, R. Ciccocioppo, Peptides 27, 3284–3291 (2006)
M.A. Pelleymounter, M.J. Cullen, M.B. Baker, R. Hecht, D. Winters, T. Boone, F. Collins, Science 269, 540–543 (1995)
C.Y. Chen, A. Inui, A. Asakawa, K. Fujino, I. Kato, C.C. Chen, N. Ueno, M. Fujimiya, Gastroenterology 129, 8–25 (2005)
T. Nozu, V. Martinez, J. Rivier, Y. Tache, Am. J. Physiol. 276, G867–G874 (1999)
C. Tanaka, A. Asakawa, M. Ushikai, T. Sakoguchi, H. Amitani, M. Terashi, K. Cheng, H. Chaolu, N. Nakamura, A. Inui, Biochem. Biophys. Res. Commun. 390, 887–891 (2009)
G. Wittmann, T. Fuzesi, Z. Liposits, R.M. Lechan, C. Fekete, J. Comp. Neurol. 517, 825–840 (2009)
M.T. Lin, P.C. Chu, S.Y. Leu, Neuroendocrinology 37, 206–211 (1983)
J.P. Duggan, D.A. Booth, Science 231, 609–611 (1986)
A. Inui, Cancer Res. 59, 4493–4501 (1999)
A. Rodriguez-Membrilla, V. Martinez, P. Vergara, J. Pharmacol. Exp. Ther. 275, 486–493 (1995)
J. Czimmer, M. Million, Y. Tache, Am. J. Physiol. Gastrointest. Liver Physiol. 290, G511–G518 (2006)
A. Korosi, J.G. Veening, T. Kozicz, M. Henckens, J. Dederen, L. Groenink, J. van der Gugten, B. Olivier, E.W. Roubos, Brain Res. 1072, 46–54 (2006)
F. Holsboer, A. Gerken, A. Steiger, O. Benkert, O.A. Muller, G.K. Stalla, Lancet 1, 55 (1984)
J.M. Reul, F. Holsboer, Curr. Opin. Pharmacol. 2, 23–33 (2002)
T.L. Bale, W.W. Vale, Annu. Rev. Pharmacol. Toxicol. 44, 525–557 (2004)
E.R. de Kloet, M. Joëls, F. Holsboer, Nat. Rev. Neurosci. 6, 463–475 (2005)
T. Kozicz, Gen. Comp. Endocrinol. 153, 235–240 (2007)
A.L. Sharpe, T.J. Phillips, Behav. Pharmacol. 20, 346–351 (2009)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ushikai, M., Asakawa, A., Sakoguchi, T. et al. Centrally administered urocortin 3 inhibits food intake and gastric emptying in mice. Endocr 39, 113–117 (2011). https://doi.org/10.1007/s12020-010-9420-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-010-9420-7